{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:23:44Z","timestamp":1770499424286,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1016\/s0016-5085(03)00382-2","type":"journal-article","created":{"date-parts":[[2003,6,12]],"date-time":"2003-06-12T19:58:58Z","timestamp":1055447938000},"page":"1774-1785","source":"Crossref","is-referenced-by-count":596,"title":["Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn\u2019s disease"],"prefix":"10.1016","volume":"124","author":[{"given":"Jan M.H","family":"Van den Brande","sequence":"first","affiliation":[]},{"given":"Henri","family":"Braat","sequence":"additional","affiliation":[]},{"given":"Gijs R","family":"van den Brink","sequence":"additional","affiliation":[]},{"given":"Henri H","family":"Versteeg","sequence":"additional","affiliation":[]},{"given":"Christiaan A","family":"Bauer","sequence":"additional","affiliation":[]},{"given":"Inge","family":"Hoedemaeker","sequence":"additional","affiliation":[]},{"given":"Catherine","family":"van Montfrans","sequence":"additional","affiliation":[]},{"given":"Daan W","family":"Hommes","sequence":"additional","affiliation":[]},{"given":"Maikel P","family":"Peppelenbosch","sequence":"additional","affiliation":[]},{"given":"Sander J.H","family":"van Deventer","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0016-5085(03)00382-2_BIB1","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/gast.2000.18160","article-title":"Tumor necrosis factor","volume":"119","author":"Papadakis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.40.4.443","article-title":"Tumour necrosis factor and Crohn\u2019s disease","volume":"40","author":"Van Deventer","year":"1997","journal-title":"Gut"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/385733a0","article-title":"Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha","volume":"385","author":"Moss","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.iy.10.040192.002211","article-title":"The pathophysiology of tumor necrosis factors","volume":"10","author":"Vassalli","year":"1992","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB6","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/0016-5085(94)90398-0","article-title":"Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease","volume":"106","author":"Breese","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2249.1993.tb05997.x","article-title":"Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn\u2019s disease","volume":"94","author":"Reinecker","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0140-6736(92)90999-J","article-title":"Tumour necrosis factor alpha in stool as a marker of intestinal inflammation","volume":"339","author":"Braegger","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jcp.46.8.757","article-title":"Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea","volume":"46","author":"Nicholls","year":"1993","journal-title":"J Clin Pathol"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ibd.3780050209","article-title":"Antitumor necrosis factor therapy for inflammatory bowel disease","volume":"5","author":"Sandborn","year":"1999","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","article-title":"Anti-TNF alpha therapy of rheumatoid arthritis","volume":"19","author":"Feldmann","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB12","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0161-5890(93)90106-L","article-title":"Construction and initial characterization of a mouse-human chimeric anti-TNF antibody","volume":"30","author":"Knight","year":"1993","journal-title":"Mol Immunol"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB13","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn\u2019s disease. Crohn\u2019s Disease cA2 Study Group","volume":"337","author":"Targan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0016-5085(95)90277-5","article-title":"Treatment of Crohn\u2019s disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)","volume":"109","author":"van Dullemen","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB15","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.151.3.1548","article-title":"Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists","volume":"151","author":"Mohler","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB16","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-130-6-199903160-00004","article-title":"Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial","volume":"130","author":"Moreland","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB17","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.1780361206","article-title":"Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha","volume":"36","author":"Elliott","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn\u2019s disease","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB19","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.4049\/jimmunol.166.10.6399","article-title":"Apoptosis","volume":"166","author":"Bu","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0016-5085(99)70177-0","article-title":"Lamina propria T cells in Crohn\u2019s disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis","volume":"116","author":"Boirivant","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB21","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.4049\/jimmunol.163.2.1081","article-title":"Resistance of Crohn\u2019s disease T cells to multiple apoptotic signals is associated with a Bcl-2\/Bax mucosal imbalance","volume":"163","author":"Ina","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.50.2.206","article-title":"Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn\u2019s disease","volume":"50","author":"ten Hove","year":"2002","journal-title":"Gut"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB23","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1053\/gast.2001.28702","article-title":"Infliximab induces apoptosis in monocytes from patients with chronic active Crohn\u2019s disease by using a caspase-dependent pathway","volume":"121","author":"Lugering","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-1759(86)90322-4","article-title":"A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor\/tumor necrosis factor from human monocytes","volume":"95","author":"Espevik","year":"1986","journal-title":"J Immunol Methods"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB25","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","article-title":"Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha","volume":"179","author":"Sallusto","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB26","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.4049\/jimmunol.161.10.5245","article-title":"Glucocorticoids inhibit bioactive IL-12 p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential","volume":"161","author":"Vieira","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB27","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1172\/JCI108719","article-title":"Isolation and functional characterization of human intestinal mucosal lymphoid cells","volume":"59","author":"Bull","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/eji.1830220105","article-title":"The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria","volume":"22","author":"Van Tol","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1172\/JCI2676","article-title":"Immunosuppressive properties of methotrexate","volume":"102","author":"Genestier","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0167-5699(99)01547-9","article-title":"T-cell priming by type-1 and type-2 polarized dendritic cells","volume":"20","author":"Kalinski","year":"1999","journal-title":"Immunol Today"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB31","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1002\/eji.1830251204","article-title":"A sensitive assay for detecting low-affinity interactions at the cell surface reveals no additional ligands for the adhesion pair rat CD2 and CD48","volume":"25","author":"Brown","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/jpet.301.2.418","article-title":"Binding and functional comparisons of two types of tumor necrosis factor antagonists","volume":"301","author":"Scallon","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199707173370301","article-title":"Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein","volume":"337","author":"Moreland","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ijc.2910380109","article-title":"The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy","volume":"38","author":"Gottlinger","year":"1986","journal-title":"Int J Cancer"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB35","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1084\/jem.177.6.1575","article-title":"The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation","volume":"177","author":"Aversa","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB36","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.171.3.941","article-title":"A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor\/cachectin by activated normal human T cells","volume":"171","author":"Kinkhabwala","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB37","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1348-0421.1994.tb02160.x","article-title":"Tumor necrosis factor receptor expression in HIV-1-infected CD4+ T cells","volume":"38","author":"Hober","year":"1994","journal-title":"Microbiol Immunol"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/cyto.1995.0029","article-title":"Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions","volume":"7","author":"Scallon","year":"1995","journal-title":"Cytokine"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB39","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1084\/jem.180.6.2173","article-title":"Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis","volume":"180","author":"Evans","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB40","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0021-9258(18)52357-7","article-title":"Antibody-induced dimerization activates the epidermal growth factor receptor tyrosine kinase","volume":"266","author":"Spaargaren","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB41","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/emboj\/18.8.2119","article-title":"A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in \u2018reverse signalling\u2019","volume":"18","author":"Watts","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB42","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/75068","article-title":"Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation","volume":"6","author":"Atreya","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB43","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0016-5085(99)70392-6","article-title":"Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice","volume":"117","author":"Fuss","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB44","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0092-8674(95)90192-2","article-title":"The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor","volume":"83","author":"Grell","year":"1995","journal-title":"Cell"},{"key":"10.1016\/S0016-5085(03)00382-2_BIB45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0014-5793(97)00553-X","article-title":"Cell death induction by receptors of the TNF family","volume":"410","author":"Wallach","year":"1997","journal-title":"FEBS Lett"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508503003822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508503003822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T11:02:44Z","timestamp":1682506964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508503003822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["S0016508503003822"],"URL":"https:\/\/doi.org\/10.1016\/s0016-5085(03)00382-2","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}